Members of the PhD Board and PhD candidates are actively involved in a range of Third Mission activities, making a significant contribution to the development of clinical research, health promotion and protection initiatives, public engagement activities, the valorization of intellectual and industrial property, and initiatives aimed at fostering the empowerment of citizens and patients.
I – Clinical Research
Members of the PhD Board participate in numerous national and international clinical studies, contributing to the advancement of translational research and strengthening collaborations with local companies and institutions, as well as with international scientific partners.
II – Health Protection and Promotion Initiatives
Several members of the PhD Board, with the involvement of PhD candidates, promote and participate in initiatives dedicated to disease prevention and the protection of public health.
III – Public Engagement Activities
Faculty members actively take part in science communication initiatives addressed to the general public. These activities include the publication of outreach articles, participation in radio and television programs, the management and updating of informative websites, and orientation and interaction activities with schools, thereby contributing to the dissemination of scientific culture in society.
IV – Valorization of Intellectual and Industrial Property
Members of the PhD Board are also involved in the valorization of research results through intellectual property protection activities. Several faculty members hold national and international patents.
-
Professors: Sorice, Misasi, Garofalo, Manganelli, Longo. Process and kit for the in vitro diagnosis of the antiphospholipid antibody syndrome. International classification: G01N33/564. Application number: WO2022IB50708 (27/01/2022). Priority number: IT20210002306 (03/02/2021).
-
Professor: Sorice. Complexes between phospholipids and protein vimentin, and in vitro methods for the detection of antibodies against these complexes. International patent: WO2010121714. Italian patent No. 1,396,046 (2010).
-
Professor: Pulcinelli. Method to identify and treat subjects resistant to acetylsalicylic acid. Patent: EPI-11648.
V – Citizen Empowerment
Third Mission activities also include initiatives aimed at strengthening the active role of citizens in prevention, diagnosis, and care pathways. In this context, several members of the PhD Board participate in the activities of specialized clinical and diagnostic centers contributing to the development of information and support programs for patients and their families.